Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc.
FOLD
Valuace
100
Růst
86
Zdraví
71
Cena
$ 8.92
Dnes
+0.02 (0.14%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.8B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
-167
PS
7
Cena 1R
6-14
⌀ Cena
8.17
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
29-04-2026
Poslední dividenda

Profil

Amicus Therapeutics, Inc., biotechnologická společnost, se zaměřuje na objevování, vývoj a dodávání léků pro vzácná onemocnění. Jeho komerční produkt a produkt kandiduje na Galafold, perorální precizní lék pro léčbu dospělých s potvrzenou diagnózou Fabryho choroby a upravitelnou variantou genu galaktosidázy alfa na základě testovacích dat in vitro. Vyvíjí také AT-GAA, nové léčebné paradigma Pompeho nemoci; enzymatickou substituční terapii Pompeho nemoci; CLN3, který je ve fázi 1/2 klinické studie pro hodnocení bezpečnosti a účinnosti jednorázového intratekálního podání AAV sérotypu AT-GTX-502 genové terapie u pacientů s CLN3; a CDKL5, gen X-chromozomu kódující CDKL5 protein, který reguluje expresi nezbytných proteinů pro normální vývoj mozku. Společnost uzavřela licenční smlouvy s Dětskou nemocnicí, Pensylvánskou univerzitou a firmou GlaxoSmithKline. Amicus Therapeutics, Inc. byla založena v roce 2002 a sídlí ve Filadelfii v Pensylvánii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
499
Založení
2007-05-31
Adresa
3675 Market Street
CEO
Bradley L. Campbell

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues634.2634.2528.3399.4329.2305.5260.9182.291.236.95.00.01.20.418.421.40.9
Cost of Revenues76.780.452.937.338.634.531.022.014.46.20.80.00.00.00.00.00.0
Gross Profit557.5553.8475.4362.0290.6271.0229.8160.376.830.74.10.01.20.418.421.40.9
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues185.2169.1154.7125.2149.7141.5126.7110.4115.1103.5
Cost of Revenues28.421.315.211.714.813.311.313.613.59.9
Gross Profit156.8147.7139.5113.6134.9128.2115.496.8101.693.6
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0152.4276.7272.0308.4286.4270.9149.3104.876.947.641.950.350.939.0
Selling General & Admin Expenses0.00.00.0275.3213.0192.7156.4169.9127.288.771.247.320.718.919.419.915.7
Depreciation & Amortization7.57.58.57.912.53.811.3-28.24.23.63.21.81.51.71.71.62.1
Total Operating Expenses524.7519.3450.5427.7495.1471.0473.7461.0402.3241.6179.2126.069.962.671.372.356.8
Operating Income32.834.524.9-73.5-204.4-199.9-243.9-300.7-328.8-442.0-181.9-130.4-68.7-64.2-52.9-50.9-55.8
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.035.040.7
Selling General & Admin Expenses0.00.00.00.00.00.00.00.070.265.7
Depreciation & Amortization1.91.91.91.82.02.22.22.22.22.2
Total Operating Expenses140.8113.5148.9121.5118.9106.6100.4124.6105.3106.4
Operating Income15.934.3-9.5-8.016.021.715.0-27.7-3.7-17.0
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income3.33.35.47.13.00.53.210.210.54.11.60.90.20.20.30.20.2
Interest Expense46.246.249.650.137.132.522.418.922.417.25.41.61.50.00.10.10.3
Other Expense-32.6-34.3-53.6-76.6-37.6-41.6-30.4-55.2-11.7-225.1-24.9-5.4-0.1-1.10.72.8-0.1
IBT0.20.2-28.8-150.1-242.0-241.6-274.3-355.9-349.1-449.1-203.8-132.1-70.0-63.1-52.0-48.0-56.1
Income Tax Expense27.327.327.41.5-5.58.92.60.5-0.1-165.1-3.71.5-1.1-3.5-3.2-3.6-1.1
Net Income-27.1-27.1-56.1-151.6-236.6-250.5-276.9-356.4-349.0-284.0-200.0-132.1-68.9-59.6-48.8-44.4-54.9
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.80.80.80.81.41.11.41.51.71.5
Interest Expense11.411.711.611.512.012.712.512.412.813.0
Other Expense-12.80.0-9.7-10.1-8.0-14.9-14.9-15.9-28.0-7.7
IBT3.134.3-19.2-18.07.96.80.1-43.6-31.7-24.7
Income Tax Expense1.517.05.23.6-6.813.515.84.82.23.1
Net Income1.717.3-24.4-21.714.7-6.7-15.7-48.4-33.8-21.6
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-0.51$-0.82$-0.92$-1.07$-1.48$-1.88$-1.85$-1.49$-1.20$-0.93$-1.16$-1.07$-1.28$-1.98
EPS Diluted$0.00$0.00$0.00$-0.51$-0.82$-0.92$-1.07$-1.48$-1.88$-1.85$-1.49$-1.20$-0.93$-1.16$-1.07$-1.28$-1.98
Shares Outstanding309.0308.4304.4295.2289.1271.4258.9240.4185.8153.4134.4109.974.451.345.634.627.7
Diluted Shares Outstanding314.4308.4304.4295.2289.1271.4258.9240.4185.8153.4134.4109.974.451.345.634.627.7
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.12$-0.07
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.12$-0.07
Shares Outstanding309.0308.5308.3307.7299.0304.7303.8302.9293.6295.8
Diluted Shares Outstanding314.4310.4308.3307.7299.0304.7303.8302.9293.6295.8
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents209.3213.8247.0148.8245.2163.2142.879.749.1187.069.524.143.634.025.729.6
Short Term Investments50.736.239.2144.8237.3320.0309.9424.4309.5143.3144.5127.638.465.230.077.9
Total Cash & ST Investments260.1249.9286.2293.6482.5483.3452.7504.2358.6330.4214.0151.782.099.155.7107.4
Accounts Receivable85.2101.187.666.252.746.933.322.09.51.30.00.00.83.25.00.0
Inventory81.3118.859.723.826.819.614.08.44.63.40.00.00.00.00.00.0
Other Current Assets35.134.949.540.234.829.720.016.619.35.02.62.95.52.35.92.2
Total Current Assets461.7504.7483.1423.8596.8579.5520.1551.1392.0340.1216.6154.688.3104.666.6109.7
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents190.6158.7181.7213.8233.6209.3209.8247.0263.3211.3
Short Term Investments73.372.368.936.216.150.729.839.217.054.3
Total Cash & ST Investments263.8231.0250.6249.9249.8260.1239.6286.2280.3265.6
Accounts Receivable113.8105.888.3101.198.185.276.487.673.363.7
Inventory177.9154.9132.4118.8115.381.360.859.756.951.4
Other Current Assets38.546.339.534.935.335.154.449.552.752.1
Total Current Assets594.1538.0510.8504.7498.5461.7431.2483.1463.3432.8
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment53.851.758.060.363.167.281.011.49.19.86.22.84.15.02.42.6
Goodwill197.8197.8197.8197.8197.8197.8197.8197.8197.8197.8197.811.611.60.00.00.0
Intangible Assets18.917.220.523.023.023.023.023.023.0486.7486.723.023.00.00.00.0
Long-Term Investments3.00.00.00.0-4.9-4.9-5.1-6.5-6.5-173.80.017.50.00.00.00.0
Other Long-Term Assets14.313.618.614.324.419.128.36.75.22.51.10.50.60.40.70.3
Total Long-Term Assets287.8280.3294.8300.4308.3307.1330.1238.9235.1696.8691.855.439.35.53.12.9
Total Assets749.5785.0777.9724.2905.1886.5850.2790.0627.01,036.8908.4210.0127.6110.169.8112.6
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment49.350.650.951.753.653.855.458.060.658.3
Goodwill197.8197.8197.8197.8197.8197.8197.8197.8197.8197.8
Intangible Assets14.715.616.417.218.018.919.720.521.322.1
Long-Term Investments0.03.30.00.00.00.00.03.13.03.0
Other Long-Term Assets12.910.114.013.618.717.417.715.521.119.0
Total Long-Term Assets274.7277.3279.0280.3288.1287.8290.6294.8300.8297.3
Total Assets868.8815.3789.8785.0786.6749.5721.8777.9764.1730.1
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable32.112.915.115.421.517.1120.480.67.941.016.516.32.18.82.60.0
Short-Term Debt8.18.516.68.67.46.97.20.00.30.30.03.80.30.41.01.3
Other Current Liabilities127.9109.2123.5110.1117.1105.71.35.561.90.357.110.58.06.77.18.3
Current Liabilities168.1148.7167.7139.0146.0129.7128.886.170.0111.073.620.210.59.219.316.2
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable19.113.914.512.913.532.19.215.123.213.5
Short-Term Debt8.78.68.68.58.58.18.316.615.515.7
Other Current Liabilities171.2145.1129.9109.2136.1127.9124.6123.5130.8130.0
Current Liabilities198.9167.6152.9148.7158.1168.1142.1167.7169.5159.2
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt388.9435.2436.7443.6432.7434.9203.0321.7164.2154.541.610.514.20.30.01.0
Capital Leases47.053.557.260.150.852.560.70.00.30.30.00.00.00.00.00.0
Def. Tax Liability0.00.00.04.94.94.95.16.56.5173.8176.29.29.20.00.00.0
Total Liabilities617.0591.0617.7601.1597.8600.1373.8447.0274.2676.7560.687.881.840.940.247.6
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt434.2434.7434.9435.2436.1435.9436.2436.7499.0495.3
Capital Leases50.852.052.853.555.255.156.148.960.258.8
Def. Tax Liability0.00.00.00.00.00.00.00.0-5.9-5.9
Total Liabilities638.4611.0596.3591.0607.7617.0591.1617.7630.8618.5
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock2.92.92.92.82.82.72.61.91.71.51.31.00.70.60.40.4
Retained Earnings-2,748.2-2,740.2-2,684.1-2,532.5-2,295.9-2,045.5-1,768.6-1,412.2-1,063.6-779.6-579.6-447.4-378.5-318.9-270.1-225.7
Comprehensive Income8.95.15.2-12.15.08.22.80.1-2.12.0-0.1-0.10.00.00.00.0
Total Common Equity132.5194.0160.2123.0307.4286.4476.4342.9352.9360.2347.8122.245.869.229.664.9
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock3.03.03.02.92.92.92.92.92.92.9
Retained Earnings-2,769.0-2,786.3-2,761.9-2,740.2-2,754.9-2,748.2-2,732.5-2,684.1-2,650.2-2,628.7
Comprehensive Income22.830.812.85.125.08.86.65.3-6.84.2
Total Common Equity230.4204.3193.6194.0178.8132.5130.7160.2133.2111.6
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt444.1443.6445.1452.1440.1441.7210.2321.7164.5154.541.614.414.50.71.02.3
Book Value132.5194.0160.2123.0307.4286.4476.4342.9352.9360.2347.8122.245.869.229.664.9
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value230.4204.3193.6194.0178.8132.5130.7160.2133.2111.6
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-119.5-27.1-56.1-151.6-236.6-250.5-276.9-356.4-349.0-284.0-200.0-132.1-68.9-59.6-48.8-44.4-54.9
Depreciation & Amortization8.72.68.57.95.36.28.84.84.23.63.21.81.51.71.71.62.1
Stock-Based Compensation81.687.484.986.176.557.849.244.429.323.117.510.06.06.26.28.76.2
Change Working Capital-43.3-39.6-98.9-48.0-39.9-18.6-32.111.6-4.7-25.81.114.39.44.97.8-12.531.2
Change In Accounts Receivable-23.3-5.9-19.5-20.1-17.3-8.2-11.2-11.1-13.3-7.7-1.40.01.12.51.80.00.0
Change In Accounts Payable20.282.8-16.549.2-6.47.4-10.646.717.112.67.115.56.2-0.6-0.9-1.3-1.3
Change In Inventories-44.0-111.5-73.7-44.6-5.3-7.8-4.6-5.1-4.2-0.9-3.70.02.3-3.23.60.00.0
Other Non-cash Items136.19.927.741.528.02.517.846.614.3234.931.44.90.32.0-0.6-2.81.4
Cash from Operations-41.90.00.0-69.1-166.6-202.5-233.3-250.4-300.0-215.5-150.5-100.1-51.7-45.8-33.7-49.4-14.0
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income1.717.3-24.4-21.714.7-6.7-15.7-48.4-33.8-21.6
Depreciation & Amortization-3.01.91.91.82.02.22.22.22.22.2
Stock-Based Compensation26.618.117.625.219.218.716.230.818.116.5
Change Working Capital-6.7-9.9-29.16.0-43.7-44.011.1-22.30.7-32.7
Change In Accounts Receivable-0.6-8.1-12.515.3-10.4-8.6-10.09.6-11.5-11.3
Change In Accounts Payable38.130.610.43.6-5.0-14.127.1-24.58.19.5
Change In Inventories-44.3-36.3-22.6-8.3-12.0-34.7-25.2-1.7-2.4-14.8
Other Non-cash Items-2.38.37.5-3.63.86.98.98.144.6-5.9
Cash from Operations0.00.00.00.00.00.00.00.03.5-38.3
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-6.2-3.3-3.6-7.4-3.8-3.9-3.2-20.0-6.3-4.5-6.0-4.8-0.2-0.7-4.3-1.4-0.4
Acquisitions23.80.00.00.00.03.93.220.06.30.00.0-141.10.00.00.00.00.0
Investments-129.1-94.4-114.8-91.7-243.3-341.4-365.2-383.9-578.4-490.5-219.9-289.6-162.8-56.6-118.5-50.6-113.7
Sales of Investment132.751.3117.8197.2335.9424.0354.8499.0463.5323.8221.4290.155.983.383.498.594.6
Other Investing Activities-14.40.00.00.03.4-3.9-3.2-20.0-6.30.00.00.00.00.00.00.00.0
Cash from Investing-2.60.00.098.192.378.8-13.695.2-121.2-171.2-4.5-145.3-107.126.1-39.446.5-19.4
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.3-0.4-2.4-0.2-0.3-0.4-1.1-1.8-1.7-1.6
Acquisitions0.00.00.00.00.00.00.00.022.21.6
Investments-23.1-18.2-14.4-38.8-36.0-4.9-44.3-29.6-38.6-16.7
Sales of Investment16.917.311.06.215.939.523.438.916.454.0
Other Investing Activities0.00.00.00.00.00.00.00.0-22.2-1.6
Cash from Investing0.00.00.00.00.00.00.00.0-24.035.8
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-21.00.00.0-21.0-0.3-0.5-155.3-0.4-0.3-0.3-80.2-15.3-0.3-0.4-1.3-1.3-1.6
Debt Issued12.9443.6-1.413.912.3-1.1386.8-111.1157.610.3193.142.50.214.21.00.03.9
Issuance of Common Stock73.10.00.092.90.0199.80.0189.0294.6243.097.1243.0135.815.080.245.245.2
Repurchase of Common Stock-20.60.00.00.0-11.50.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities-15.80.00.0-20.64.312.8418.228.9156.54.7255.863.13.714.82.6-44.90.0
Cash from Financing31.70.00.061.7-7.5212.1262.9217.5450.8247.4272.7290.9139.229.481.5-0.943.7
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-20.90.0
Debt Issued442.8-0.5-0.2-0.2-1.00.6-0.4-0.611.62.2
Issuance of Common Stock0.00.00.00.00.00.00.00.029.836.6
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-0.71.1
Cash from Financing0.00.00.00.00.00.00.00.08.237.6
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-2.00.6-33.497.0-96.383.319.864.031.1-138.0117.545.4-19.69.78.3-3.910.2
Closing Cash Balance209.3217.3216.7250.1153.1249.5166.2146.382.449.1187.069.524.143.634.025.729.6
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash23.531.9-22.7-32.0-20.124.5-0.4-37.3-16.351.9
Closing Cash Balance214.0190.6162.0184.7216.7236.8212.4212.8247.0266.3
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-48.129.8-37.4-76.5-170.3-206.4-236.5-270.4-306.3-220.0-156.5-105.0-51.9-46.5-38.1-50.8-14.4
Real Free Cash Flow-129.7-57.6-122.3-162.6-246.9-264.2-285.7-314.9-335.5-243.1-174.0-114.9-57.9-52.7-44.3-59.5-20.6
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow16.035.3-28.97.5-4.2-23.321.6-31.51.7-39.9
Real Free Cash Flow-10.617.2-46.5-17.6-23.4-42.05.4-62.3-16.4-56.4
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-167.3-16.8-1.4
P/S7.216.69.4
P/B19.795.2
P/FCF-78.8-11.6-1.5
Market cap$2.8$2.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %26 %0 %
Debt to Income-1633.4 %-184.7 %0 %
Debt to Free cash flow-769.3 %-1094.2 %0 %
Interest expense percentage140.8 %12.7 %44.7 %
Current ratio3 5.5 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-11.8 %-88.8 %0 %
ROA-3.1 %-34.3 %0 %
CapEx to Revenue0.5 %41 %0 %
RaD to Revenue0 %2055.2 %0 %
ROEM1,270,961.9 223845.1

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin87.9 %81.5 %68.7 %
Operating margin5.2 %-3065.3 %35.5 %
Net margin-4.3 %-2748.4 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %-0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding314.4 mil 174.1 mil
Employee count0.5 tis 0.3 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader